AI English summary of an SEC filing — figures as filed
Humana HUMHumana said it entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a BlackRock unit. The new joint venture replaces the existing joint ventures with WCAS-affiliated funds and CenterWell, and BlackRock will acquire WCAS's current equity stake.
Key points
AI summaryHumana said it entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a BlackRock unit. The new joint venture replaces the existing joint ventures with WCAS-affiliated funds and CenterWell, and BlackRock will acquire WCAS's current equity stake.
The company said BlackRock will acquire WCAS's current equity stake, valued at about $2.8 billion, and that the target is a network of nearly 150 CenterWell Senior Primary Care clinics. BlackRock will hold a majority stake in the new joint venture, and CenterWell will hold a minority stake.
The company said the new joint venture does not include a put option exercisable by BlackRock, and that removing the put arrangements for the existing joint ventures will significantly reduce liabilities on its balance sheet. It said the minimum return protections will be recorded as a derivative instrument at fair value, and it expects its cost of capital to be significantly lower.
The company said CenterWell will have the option to buy clinics from the joint venture beginning in 2028, and that if it has not acquired all clinics by the end of 2033, BlackRock may exit through a sale process. Humana also reaffirmed its 2026 adjusted EPS guidance of at least $9.00, and said it expects the transaction to close in Q4 2026.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
BlackRock Joint Venture Replaces WCAS Joint Venture
Humana said it entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a BlackRock unit. The new joint venture replaces the existing joint ventures with WCAS-affiliated funds and CenterWell, and BlackRock will acquire WCAS's current equity stake.
Source · Based on the filing body and exhibits
WCAS Stake Valued at About $2.8 billion, Nearly 150 Clinics
The company said BlackRock will acquire WCAS's current equity stake, valued at about $2.8 billion, and that the target is a network of nearly 150 CenterWell Senior Primary Care clinics. BlackRock will hold a majority stake in the new joint venture, and CenterWell will hold a minority stake.
Source · Based on the filing body and exhibits
No Put Option, Derivative Recognition and Liability Reduction Expected
The company said the new joint venture does not include a put option exercisable by BlackRock, and that removing the put arrangements for the existing joint ventures will significantly reduce liabilities on its balance sheet. It said the minimum return protections will be recorded as a derivative instrument at fair value, and it expects its cost of capital to be significantly lower.
Source · Based on the filing body and exhibits
Clinic Purchase Option and 2026 Adjusted EPS Guidance Reaffirmed
The company said CenterWell will have the option to buy clinics from the joint venture beginning in 2028, and that if it has not acquired all clinics by the end of 2033, BlackRock may exit through a sale process. Humana also reaffirmed its 2026 adjusted EPS guidance of at least $9.00, and said it expects the transaction to close in Q4 2026.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…